Development of Gs-selective inhibitory compounds.
Nanoff
Christian
C
Institute of Pharmacology, University of Vienna, A-1090 Vienna, Austria.
Kudlacek
Oliver
O
Freissmuth
Michael
M
D000818:Animals; D001557:Benzenesulfonates / Q000494:pharmacology*; D002460:Cell Line; D019205:GTP-Binding Protein alpha Subunits, Gs / Q000037:antagonists & inhibitors* / Q000502:physiology; D016244:Guanosine 5'-O-(3-Thiotriphosphate) / Q000378:metabolism; D006153:Guanosine Diphosphate / Q000378:metabolism; D006160:Guanosine Triphosphate / Q000378:metabolism; D007700:Kinetics; D011869:Radioligand Assay / Q000379:methods; D011956:Receptors, Cell Surface / Q000502:physiology; D011994:Recombinant Proteins / Q000037:antagonists & inhibitors / Q000378:metabolism; D015398:Signal Transduction; D018411:Spodoptera; D013462:Sulfur Radioisotopes; D013498:Suramin / Q000031:analogs & derivatives / Q000493:pharmacokinetics / Q000494:pharmacology*; D014316:Tritium
C110258:4,4,',4'',4'''-(carbonylbis(imino-5,1,3-benzenetriylbis(carbonylimino)))tetrakis(benzene-1,3-disulfonate); D001557:Benzenesulfonates; D011956:Receptors, Cell Surface; D011994:Recombinant Proteins; D013462:Sulfur Radioisotopes; D014316:Tritium; D006153:Guanosine Diphosphate; D016244:Guanosine 5'-O-(3-Thiotriphosphate); D013498:Suramin; D006160:Guanosine Triphosphate; D019205:GTP-Binding Protein alpha Subunits, Gs